Guardian 8 Holdings, through its wholly owned subsidiary, Guardian 8 Corporation, develops and manufactures innovative personal security devices designed to deliver layered defense for low-impact de-escalation and risk mitigation. It’s initial product, the G8 ProV2 leverages a...

Omni Bio Pharmaceutical, Inc. (OTCBB: OMBP) is a clinical-stage biopharmaceutical company that has licensed potential new therapies currently in development for an existing FDA approved drug – Alpha-1 antitrypsin (AAT). Their strategy is to advance new therapies...

Native American Energy Group, Inc. operates as a development-stage energy resource development and management company. The company engages in the acquisition and management of Native American land and fee land acreage in Montana and Alaska; and the...

Retrophin, Inc. (OTCQB: RTRX) is a publicly-traded New York-based biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases. Retrophin is currently developing treatments for Focal Segmental Glomerulosclerosis (FSGS), Pantothenate Kinase-Associated Neurodegeneration (PKAN), Duchenne...